Surgical menopause is when surgery, rather than the natural aging process, causes a woman to go through menopause. Surgical menopause occurs after an oophorectomya surgery that removes the ovaries. The ovaries are the main source of estrogen production in the female body.
This blog aims to help women who have had the menopause induced through surgery for endometriosis make more informed health decisions at a time of significant change for their mind and body. Most women have heard of the menopause. They fear it, but for a select few women the menopause is a relief and a respite from the years of agony and pain from endometriosis that few people seem to understand.
Hormones are chemicals the body naturally makes to control the growth and activity of normal cells. Hormones can also speed the growth of some types of cancer. For example, the hormones estrogen and progesterone can stimulate the growth of some breast tumors.
According to an article published in the Archives of Internal Medicinepostmenopausal women who experience new pain in their breasts while taking hormone replacement therapy may have an increased risk of developing breast cancer. Postmenopausal hormone therapy that includes estrogen can relieve these symptoms, but the risks and benefits of hormone therapy must be carefully weighed for each woman. Previous reports suggest that the combination of estrogen plus progestin, for example, increases the risk of breast cancer, heart disease, stroke, and blood clots, but decreases the risk of colorectal cancer and bone fractures.
Pelvic organ prolapse is estimated to affect up to one-half of all women, causing pain and interfering with sexual function. A new study demonstrates how an ultralow dose of vaginal estriol gel used before and after pelvic organ prolapse surgery can improve recovery time and results. Pelvic organ prolapse, also known as dropped bladder or dropped vagina, is essentially a weakening of the vaginal tissues that causes a descent of a pelvic organ into or beyond the vagina, perineum, or anal canal.
Taking post-menopausal hormone therapy PHTalso called hormone replacement therapy HRTto help with menopause symptoms may not be safe for women who have had breast cancer. If you are bothered by menopause symptoms, talk to your doctor about other ways to get help. Many women have menopause symptoms such as hot flashes after treatment for breast cancer.
Skip to Content. Use the menu to see other pages. Care for people diagnosed with cancer does not end when active treatment has finished.
More women are now living for many years after breast cancer treatments. But when treatment ends, new problems can begin. For most women the end of treatment is accompanied by lingering side effects, including problems resulting from treatment that can come up years later. This is why you should keep records of your treatment including a written summary of your disease characteristics, treatments received, and complications and have regular contact with a health practitioner who knows about delayed treatment effects.
Hormones like estrogen and progesterone are chemicals produced by glands in the body. Normally, these hormones help regulate body cycles, like menstruation. However, sometimes these same hormones can cause cancer to grow.
Management of breast cancer includes systematic therapies including chemotherapy and endocrine therapy can lead to a variety of symptoms that can impair the quality of life of many breast cancer survivors. Atrophic vaginitis, caused by decreased levels of circulating estrogen to urinary and vaginal receptors, is commonly experienced by this group. Chemotherapy induced ovarian failure and endocrine therapies including aromatase inhibitors and selective estrogen receptor modulators can trigger the onset of atrophic vaginitis or exacerbate existing symptoms. Symptoms of atrophic vaginitis include vaginal dryness, dyspareunia, and irritation of genital skin, pruritus, burning, vaginal discharge, and soreness.